Yahoo Italia Ricerca nel Web

Risultati di ricerca

  1. Mary-Claire King ( Wilmette, 27 febbraio 1946) è una genetista statunitense . Dopo aver ottenuto un bachelor's degree in matematica ( cum laude) al Carleton College, si è laureata in genetica alla University of California, Berkeley. Nella sua tesi di laurea ha dimostrato tramite analisi comparativa proteica che il genoma dell' uomo ...

  2. Mary-Claire King (born February 27, 1946) is an American geneticist. She was the first to show that breast cancer can be inherited due to mutations in the gene she called BRCA1. She studies human genetics and is particularly interested in genetic heterogeneity and complex traits.

  3. «È un primo passo, ma importante per pazienti e medici» dice Mary-Claire King senza troppe illusioni: Myriad farà appello con l’appoggio dell’intera industria biotech. Però mentre stava aspettando la sentenza, ha «ricevuto un regalo». Tre ricercatori le hanno anticipato una scoperta di cui i prossimi giudici dovranno tenere conto.

  4. This month I am covering the life and career of Dr. Mary-Claire King, a distinguished scientist who has applied her talents to the good of humanity, and provides a clear ideal of what it means to truly impact society through research.

    • 4 min
  5. Mary-Claire King, Ph.D. Discovering the Hereditary Breast Cancer Gene. Research Area: Cancer Prevention. Long before scientists completed mapping the human genome in 2003, geneticist Mary-Claire King discovered BRCA1, the first gene for a hereditary form of breast cancer.

  6. 9 feb 2015 · Rina Castelnuovo for The New York Times. By Claudia Dreifus. Feb. 9, 2015. There has never been a scientific career quite like Mary-Claire Kings. Years ago, her doctoral thesis concluded...

  7. We are now developing approaches based on long-read genomic DNA sequencing and direct RNA sequencing, and are integrating Fiber-seq (developed by Andrew Stergachis) with genomic analysis of families. Representative publications: Walsh T, Casadei S, Munson KM, Eng M, Mandell JB, Gulsuner S, King M-C.